Results 171 to 180 of about 27,985 (262)

Comparative Causal Analysis of the Effects of Long-Acting Muscarinic Antagonist Versus No Long-Acting Bronchodilator Use on Readmission or Mortality After Hospitalization for Chronic Obstructive Pulmonary Disease. [PDF]

Drugs Real World Outcomes, 2020
Roberts MH, Mapel DW, Petersen H.
europepmc   +1 more source

Beneficial Effect of Muscarinic-2 Antagonist on Dilated Cardiomyopathy Induced by Autoimmune Mechanism against Muscarinic-2 Receptor

, 2001
Shinobu Matsui, Michael Fu, Mitsuru Hayase, Shogo Katsuda, Nobuo Yamaguchi, Kohei Teraoka, Takayuki Kurihara, Noboru Takekoshi   +7 more
openalex   +1 more source

Discovery, Synthesis and Characterization of a Highly Muscarinic Acetylcholine Receptor (mAChR)‐Selective M₅‐Orthosteric Antagonist, VU0488130 (ML381): A Novel Molecular Probe [PDF]

, 2014
Patrick R. Gentry, Masaya Kokubo, Thomas M. Bridges, Hyekyung P. Cho, Emery Smith, Peter Chase, Peter Hodder, Thomas J. Utley, Anuruddha Rajapakse, Frank W. Byers, Colleen M. Niswender, Ryan D. Morrison, J. Scott Daniels, Michael R. Wood, P. Jeffrey Conn, Craig W. Lindsley   +15 more
openalex   +1 more source

Critical insights into the potential risks of antipsychotic drugs to fish, including through effects on behaviour

Biological Reviews, Volume 100, Issue 5, Page 1994-2019, October 2025.
ABSTRACT Antipsychotic drugs (APDs) are a diverse class of neuroactive pharmaceuticals increasingly detected in surface and ground waters globally. Some APDs are classified as posing a high environmental risk, due, in part, to their tendency to bioaccumulate in wildlife, including fish.
Gabrielle Wasser‐Bennett, A. Ross Brown, Samuel K. Maynard, Stewart F. Owen, Charles R. Tyler   +4 more
wiley   +1 more source

Long-acting muscarinic antagonist and long-acting β₂-agonist combination for the treatment of maintenance therapy-naïve patients with chronic obstructive pulmonary disease: a narrative review. [PDF]

Ther Adv Respir Dis
Buhl R, Miravitlles M, Anzueto A, Brunton S.   +3 more
europepmc   +1 more source

Synthesis of a Muscarinic Receptor Antagonist via a Diastereoselective Michael Reaction, Selective Deoxyfluorination and Aromatic Metal-Halogen Exchange Reaction.

, 2001
Toshiaki Mase, Ioannis N. Houpis, Atsushi Akao, Ilias Dorziotis, Khateeta M. Emerson, Thoa Hoang, Takehiko Iida, Takahiro Itoh, Keisuke Kamei, Shinji Kato, M. Kawasaki, Fengrui Lang, Jaemoon Lee, Joseph P. Lynch, Peter E. Maligres, Audrey Molina, Takayuki Nemoto, Shigemitsu Okada, Robert A. Reamer, Zhiguo J. Song, David M. Tschaen, Toshihiro Wada, David Zewge, R. P. Volante, Paul J. Reider, Koji Tomimoto   +25 more
openalex   +1 more source

The Muscarinic Antagonist MT3 Distinguishes Between Form Deprivation- and Negative Lens-Induced Myopia in Chicks [PDF]

, 2014
Debora L. Nickla, Yekaterina Yusupova, Kristen Totonelly   +2 more
openalex   +1 more source

Current evidence for COPD management with dual long-acting muscarinic antagonist/long-acting β₂-agonist bronchodilators [PDF]

, 2020
NEIL SKOLNIK, Trang Susan Nguyen, Aarisha Shrestha, Riju Ray, Thomas Corbridge, Stephen Brunton   +5 more
openalex   +1 more source

Hyperhidrosis: don't sweat it

Internal Medicine Journal, Volume 55, Issue 10, Page 1626-1631, October 2025.
Abstract Hyperhidrosis is an under‐reported and under‐treated condition that causes significant patient morbidity. Secondary causes require consideration, but the vast majority of cases are idiopathic. The condition is encountered by a range of clinicians, including neurologists, dermatologists and endocrinologists, and it pays to be familiar with the ...
Mitchell J. Lycett, Karl Ng
wiley   +1 more source

Ethylatropine Bromide as a Peripherally Restricted Muscarinic Antagonist. [PDF]

ACS Chem Neurosci, 2017
Rojas A, Ganesh T, Walker A, Dingledine R.   +3 more
europepmc   +1 more source